Active, Not Recruiting
Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
NCT03641755
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Broad Institute of MIT Cambridge, Massachusetts, United States